Cannabis Growth ETF
BUDX
BUDX was delisted on the 25th of April, 2022.
2 hedge funds and large institutions have $13K invested in Cannabis Growth ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
98% less capital invested
Capital invested by funds: $660K → $13K (-$647K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.77K |
Top Sellers
BUDX Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Cannabis Growth ETF (BUDX) for Q1 2022, worth a combined $13K — down 98% from $660K a quarter earlier.
Fund positioning in BUDX was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $2.77K.
- 2 institutional investors held Cannabis Growth ETF (BUDX) as of Q1 2022, down from 3 in Q4 2021.
- Funds reported $13K of Cannabis Growth ETF stock for Q1 2022, down 98% quarter-over-quarter.
- 0 funds opened new Cannabis Growth ETF positions in Q1 2022 and 0 closed out.
- The largest Cannabis Growth ETF buyer in Q1 2022 was UBS Group, an estimated $2.77K added.
Based on aggregated 13F filings for Q1 2022.